Free Trial
NASDAQ:TCMD

Tactile Systems Technology Q3 2025 Earnings Report

Tactile Systems Technology logo
$14.84 -0.33 (-2.18%)
Closing price 04:00 PM Eastern
Extended Trading
$14.84 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tactile Systems Technology EPS Results

Actual EPS
N/A
Consensus EPS
$0.16
Beat/Miss
N/A
One Year Ago EPS
N/A

Tactile Systems Technology Revenue Results

Actual Revenue
N/A
Expected Revenue
$79.31 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tactile Systems Technology Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Monday, November 3, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

Tactile Systems Technology Earnings Headlines

URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
See More Tactile Systems Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tactile Systems Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tactile Systems Technology and other key companies, straight to your email.

About Tactile Systems Technology

Tactile Systems Technology (NASDAQ:TCMD), headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design. In addition to the therapy pumps and garments, the company offers a range of patient accessories, digital patient monitoring software and clinical training programs to support healthcare providers and ensure adherence to therapy protocols. These comprehensive solutions aim to reduce complications, such as infections or ulcerations, and improve quality of life for patients managing chronic conditions.

Founded in the mid-2000s, Tactile Systems Technology completed its initial public offering in 2013 and has since focused on expanding its commercial presence across the United States, with select distribution partnerships in Canada and international markets. The company’s field organization includes clinical specialists who collaborate with physicians, therapists and home health agencies to integrate pneumatic compression therapy into standard care pathways. Under the leadership of President and Chief Executive Officer Steve Lo, Tactile Systems continues to invest in clinical research and product innovation to broaden its portfolio and address unmet patient needs in lymphatic health management.

View Tactile Systems Technology Profile

More Earnings Resources from MarketBeat